Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates `
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis: Vaccine Market
3.2. Market Definition
3.3. Key Drivers
3.3.1. Government Immunization Programs To Eradicate Ailments From The Society
3.3.2. Rise In The Cases Of Influenza
3.3.3. Technology Advancement
3.4. Key Restraints
3.4.1. High Cost Of Development
3.4.2. Lengthy Process Of Development

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape

5. Market By Type
5.1. Quadrivalent Vaccine
5.2. Trivalent Vaccine

6. Market By Technology
6.1. Egg-Based Technology
6.2. Cell-Based Technology

7. Market By Age Group
7.1. Pediatric Age Group
7.2. Adult Age Group

8. Market By Delivery Mode
8.1. Injection
8.2. Nasal Spray

9. Geographical Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. United Kingdom
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Russia
9.2.6. Belgium
9.2.7. Poland
9.2.8. Rest Of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia & New Zealand
9.3.6. Thailand
9.3.7. Indonesia
9.3.8. Vietnam
9.3.9. Rest Of Asia Pacific
9.4. Rest Of World
9.4.1. Latin America
9.4.2. Middle East & Africa

10. Company Profiles
10.1. Merck
10.2. Novartis Ag
10.3. Pfizer, Inc
10.4. Sanofi
10.5. Biodiem
10.6. Emergent Biosolutions
10.7. F. Hoffmann-La Roche Ltd
10.8. Glaxosmithkline
10.9. Abbott
10.10. Csl Ltd



List of Figures


List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Global Influenza Vaccine Market, Growth Potential, By Type, In 2019
Figure 6: Global Influenza Vaccine Market, By Quadrivalent Vaccine, 2020-2028 (In $ Million)
Figure 7: Global Influenza Vaccine Market, By Trivalent Vaccine, 2020-2028 (In $ Million)
Figure 8: Global Influenza Vaccine Market, Growth Potential, By Technology, In 2019
Figure 9: Global Influenza Vaccine Market, By Egg-Based Technology, 2020-2028 (In $ Million)
Figure 10: Global Influenza Vaccine Market, By Cell-Based Technology, 2020-2028 (In $ Million)
Figure 11: Global Influenza Vaccine Market, Growth Potential, By Age Group, In 2019
Figure 12: Global Influenza Vaccine Market, By Pediatric Age Group, 2020-2028 (In $ Million)
Figure 13: Global Influenza Vaccine Market, By Adult Age Group, 2020-2028 (In $ Million)
Figure 14: Global Influenza Vaccine Market, Growth Potential, By Delivery Mode, In 2019
Figure 15: Global Influenza Vaccine Market, By Injection, 2020-2028 (In $ Million)
Figure 16: Global Influenza Vaccine Market, By Nasal Spray, 2020-2028 (In $ Million)
Figure 17: North America Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 18: United States Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 19: Canada Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 20: Europe Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 21: United Kingdom Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 22: Germany Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 23: France Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 24: Italy Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 25: Russia Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 26: Belgium Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 27: Poland Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 28: Rest Of Europe Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 29: Asia Pacific Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 30: China Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 31: Japan Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 32: India Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 33: South Korea Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 34: Australia & New Zealand Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 35: Thailand Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 36: Indonesia Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 37: Vietnam Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 38: Rest Of Asia Pacific Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 39: Rest Of World Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 40: Latin America Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 41: Middle East & Africa Influenza Vaccine Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - INFLUENZA VACCINE
TABLE 2: GLOBAL INFLUENZA VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: GLOBAL INFLUENZA VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: GLOBAL QUADRIVALENT VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL QUADRIVALENT VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: GLOBAL TRIVALENT VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL TRIVALENT VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: GLOBAL INFLUENZA VACCINE MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL INFLUENZA VACCINE MARKET, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: GLOBAL EGG-BASED TECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL EGG-BASED TECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 12: GLOBAL CELL-BASED TECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL CELL-BASED TECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 14: GLOBAL INFLUENZA VACCINE MARKET, BY AGE GROUP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL INFLUENZA VACCINE MARKET, BY AGE GROUP, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 16: GLOBAL PEDIATRIC AGE GROUP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL PEDIATRIC AGE GROUP MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 18: GLOBAL ADULT AGE GROUP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL ADULT AGE GROUP MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 20: GLOBAL INFLUENZA VACCINE MARKET, BY DELIVERY MODE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL INFLUENZA VACCINE MARKET, BY DELIVERY MODE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 22: GLOBAL INJECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL INJECTION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 24: GLOBAL NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 26: GLOBAL INFLUENZA VACCINE MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL INFLUENZA VACCINE MARKET, BY GEOGRAPHY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 28: NORTH AMERICA INFLUENZA VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: NORTH AMERICA INFLUENZA VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 30: EUROPE INFLUENZA VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: EUROPE INFLUENZA VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 32: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 34: REST OF WORLD INFLUENZA VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: REST OF WORLD INFLUENZA VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)